Jacobs Levy Equity Management Inc. Has $2.44 Million Stock Holdings in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH)

Jacobs Levy Equity Management Inc. boosted its holdings in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Free Report) by 50.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 533,196 shares of the company's stock after purchasing an additional 177,856 shares during the period. Jacobs Levy Equity Management Inc. owned about 0.28% of Aveanna Healthcare worth $2,437,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. KLP Kapitalforvaltning AS acquired a new stake in shares of Aveanna Healthcare in the 4th quarter valued at approximately $35,000. BNP Paribas Financial Markets acquired a new stake in Aveanna Healthcare during the 4th quarter valued at $35,000. Tower Research Capital LLC TRC lifted its stake in shares of Aveanna Healthcare by 662.2% during the 4th quarter. Tower Research Capital LLC TRC now owns 7,889 shares of the company's stock worth $36,000 after buying an additional 6,854 shares during the last quarter. Catalyst Funds Management Pty Ltd raised its holdings in Aveanna Healthcare by 321.4% in the 4th quarter. Catalyst Funds Management Pty Ltd now owns 11,800 shares of the company's stock valued at $54,000 after acquiring an additional 9,000 shares during the period. Finally, Sagespring Wealth Partners LLC bought a new position in shares of Aveanna Healthcare during the fourth quarter worth approximately $57,000. Institutional investors and hedge funds own 87.96% of the company's stock.

Insider Activity

In other news, major shareholder Robert M. Williams, Jr. sold 91,061 shares of the firm's stock in a transaction dated Thursday, May 8th. The stock was sold at an average price of $5.84, for a total transaction of $531,796.24. Following the completion of the transaction, the insider now directly owns 545,330 shares in the company, valued at $3,184,727.20. This trade represents a 14.31% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, major shareholder J.H. Whitney Equity Partners V sold 61,564 shares of the firm's stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $5.51, for a total transaction of $339,217.64. Following the transaction, the insider now owns 1,453,948 shares of the company's stock, valued at approximately $8,011,253.48. The trade was a 4.06% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 205,512 shares of company stock worth $1,173,001. Insiders own 7.80% of the company's stock.

Aveanna Healthcare Price Performance

AVAH stock traded down $0.15 during trading on Wednesday, reaching $5.61. 82,801 shares of the company were exchanged, compared to its average volume of 293,944. Aveanna Healthcare Holdings Inc. has a twelve month low of $2.32 and a twelve month high of $6.19. The company has a market capitalization of $1.09 billion, a price-to-earnings ratio of -16.44 and a beta of 2.01. The company has a 50-day moving average of $5.09 and a two-hundred day moving average of $4.94.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the stock. UBS Group boosted their target price on shares of Aveanna Healthcare from $4.50 to $5.00 and gave the company a "sell" rating in a research report on Friday, May 9th. Truist Financial cut their price target on shares of Aveanna Healthcare from $6.00 to $5.50 and set a "hold" rating for the company in a report on Friday, April 11th.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.